Entopsis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 4

Entopsis General Information

Description

Developer of novel diagnostic technologies designed to improve early detection and treatment of diseases. The company provides a universal platform to diagnose numerous diseases through urine samples, that outperforms liquid biopsies and consists of a series of time and cost-saving technologies for research and clinical testing, enabling the healthcare industry to access a suite of clinical tools that make diagnostic tests efficient.

Contact Information

Website
www.entopsis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Foundry
  • 7600 Northwest 69th Avenue
  • Medley, FL 33166
  • United States
+1 (888)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Decision/Risk Analysis
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • The Foundry
  • 7600 Northwest 69th Avenue
  • Medley, FL 33166
  • United States
+1 (888)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Entopsis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 19-Oct-2023 Cancelled Generating Revenue
7. Later Stage VC (Series A) 01-Mar-2021 Completed Product Development
6. Secondary Transaction - Private 01-Jan-2019 Completed Product Development
5. Later Stage VC 10-Jan-2017 Completed Product Development
4. Seed Round 18-Mar-2015 Completed Product Development
3. Product Crowdfunding 14-Sep-2014 Completed Product Development
2. Grant 20-Feb-2014 $1K Completed Product Development
1. Grant 01-May-2012 $160K Completed Product Development
To view Entopsis’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Entopsis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel diagnostic technologies designed to improve early detection and treatment of diseases. The company pr
Diagnostic Equipment
Medley, FL
11 As of 2023

Menlo Park, CA
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Entopsis Competitors (4)

One of Entopsis’s 4 competitors is GRAIL, a Formerly VC-backed company based in Menlo Park, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GRAIL Formerly VC-backed Menlo Park, CA
Myriad Genetics Corporation Salt Lake City, UT
Guardant Health Formerly VC-backed Palo Alto, CA
Inivata Formerly VC-backed Cambridge, United Kingdom
To view Entopsis’s complete competitors history, request access »

Entopsis Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Entopsis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4022284-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019
AU-2020340445-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019
CA-3152524-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019
US-20220398733-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019
EP-4022284-A4 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019 G01N33/57488
To view Entopsis’s complete patent history, request access »

Entopsis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entopsis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Conversant Bio Corporation Minority
G3 Capital Partners Venture Capital Minority
The Awesome Foundation Limited Partner
Breakout Labs Not-For-Profit Venture Capital
To view Entopsis’s complete investors history, request access »

Ready to get started?

Request a free trial

Entopsis FAQs

  • When was Entopsis founded?

    Entopsis was founded in 2011.

  • Where is Entopsis headquartered?

    Entopsis is headquartered in Medley, FL.

  • What is the size of Entopsis?

    Entopsis has 11 total employees.

  • What industry is Entopsis in?

    Entopsis’s primary industry is Diagnostic Equipment.

  • Is Entopsis a private or public company?

    Entopsis is a Private company.

  • What is Entopsis’s current revenue?

    The current revenue for Entopsis is .

  • How much funding has Entopsis raised over time?

    Entopsis has raised $2.69M.

  • Who are Entopsis’s investors?

    Conversant Bio, G3 Capital Partners, The Awesome Foundation, and Breakout Labs have invested in Entopsis.

  • Who are Entopsis’s competitors?

    GRAIL, Myriad Genetics, Guardant Health, and Inivata are competitors of Entopsis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »